Morgan Stanley 2seventy Bio, Inc. Transaction History

Morgan Stanley

$1.39 Trillion
Q4 2024

A detailed history of Morgan Stanley transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Morgan Stanley holds 2,917,884 shares of TSVT stock, worth $7.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,917,884

Previous 2,892,110 0.89%

Holding current value

$7.29 Million

Previous $13.7 Million 37.16%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$2.89 - $5.21 $74,486 - $134,282	25,774 Added 0.89%	2,917,884 $8.58 Million
Q3 2024 Nov 14, 2024	SELL	$3.85 - $5.05 $1.46 Million - $1.91 Million	-378,784 Reduced 11.58%	2,892,110 $13.7 Million
Q2 2024 Oct 17, 2024	SELL	$3.6 - $5.79 $3.91 Million - $6.29 Million	-1,086,612 Reduced 24.94%	3,270,894 $12.6 Million
Q2 2024 Aug 14, 2024	SELL	$3.6 - $5.79 $3.91 Million - $6.29 Million	-1,086,612 Reduced 24.94%	3,270,894 $12.6 Million
Q1 2024 Oct 17, 2024	BUY	$3.09 - $6.0 $3.36 Million - $6.52 Million	1,086,612 Added 33.22%	4,357,506 $23.3 Million
Q1 2024 Aug 16, 2024	SELL	$3.09 - $6.0 $1.5 Million - $2.91 Million	-485,304 Reduced 10.02%	4,357,506 $23.3 Million
Q1 2024 May 15, 2024	SELL	$3.09 - $6.0 $1.5 Million - $2.91 Million	-485,304 Reduced 10.02%	4,357,506 $23.3 Million
Q4 2023 Aug 16, 2024	BUY	$1.57 - $4.58 $2.47 Million - $7.2 Million	1,571,916 Added 48.06%	4,842,810 $20.7 Million
Q4 2023 Feb 13, 2024	BUY	$1.57 - $4.58 $5.48 Million - $16 Million	3,489,494 Added 257.85%	4,842,810 $20.7 Million
Q3 2023 Nov 15, 2023	BUY	$3.14 - $11.2 $1.81 Million - $6.45 Million	576,195 Added 74.14%	1,353,316 $5.3 Million
Q2 2023 Aug 14, 2023	SELL	$8.45 - $12.48 $3.28 Million - $4.84 Million	-388,205 Reduced 33.31%	777,121 $7.86 Million
Q1 2023 May 15, 2023	BUY	$9.21 - $14.98 $8.77 Million - $14.3 Million	952,227 Added 446.85%	1,165,326 $11.9 Million
Q4 2022 Feb 14, 2023	BUY	$8.57 - $17.0 $1.33 Million - $2.63 Million	154,808 Added 265.58%	213,099 $2 Million
Q3 2022 Nov 14, 2022	SELL	$12.56 - $17.54 $1.91 Million - $2.67 Million	-152,430 Reduced 72.34%	58,291 $849,000
Q2 2022 Oct 27, 2022	SELL	$10.55 - $18.81 $1.98 Million - $3.53 Million	-187,683 Reduced 47.11%	210,721 $2.78 Million
Q2 2022 Aug 15, 2022	SELL	$10.55 - $18.81 $1.98 Million - $3.53 Million	-187,683 Reduced 47.11%	210,721 $2.78 Million
Q1 2022 Oct 27, 2022	BUY	$11.67 - $26.72 $2.19 Million - $5.01 Million	187,683 Added 89.07%	398,404 $6.8 Million
Q1 2022 May 13, 2022	BUY	$11.67 - $26.72 $3.29 Million - $7.54 Million	282,046 Added 242.4%	398,404 $6.8 Million
Q4 2021 Feb 14, 2022	BUY	$13.77 - $42.56 $1.6 Million - $4.95 Million	116,358 New	116,358 $2.98 Million

Others Institutions Holding TSVT

# of Institutions

127

Shares Held

44.8M

Call Options Held

17.3K

Put Options Held

2.9K

View Full List

About 2seventy bio, Inc.

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $94.7M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

More about TSVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account